Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,181 | -4,591 | -15,712 | -13,419 | -9,035 |
| Depreciation Amortization | 19 | 9 | 41 | 35 | 25 |
| Other Working Capital | -1,216 | -1,134 | 512 | 943 | 1,249 |
| Other Operating Activity | 358 | 79 | 1,688 | 1,456 | 1,355 |
| Operating Cash Flow | $-9,020 | $-5,637 | $-13,470 | $-10,986 | $-6,406 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -75 | -75 | -44 | -24 | N/A |
| Investing Cash Flow | $-75 | $-75 | $-44 | $-24 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 29,301 | 29,301 | 29,205 |
| Other Financing Activity | -303 | -181 | -6,161 | -5,982 | -5,864 |
| Financing Cash Flow | $-303 | $-181 | $23,140 | $23,319 | $23,341 |
| Beginning Cash Position | 27,266 | 27,266 | 17,640 | 17,640 | 17,640 |
| End Cash Position | 17,868 | 21,373 | 27,266 | 29,949 | 34,575 |
| Net Cash Flow | $-9,398 | $-5,893 | $9,626 | $12,309 | $16,935 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,020 | -5,637 | -13,470 | -10,986 | -6,406 |
| Capital Expenditure | -87 | -87 | -44 | -24 | N/A |
| Free Cash Flow | -9,107 | -5,724 | -13,514 | -11,010 | -6,406 |